Expression of Survivin and Caspase-3 in Human Hepatocellular Carcinoma
Jialong Wang
Abstract
Jialong Wang
Abstract
Objective:To investigate the role of survivin and caspase-3expression in the pathogenesis of hepatocellular carcinoma (HCC).[WTHZ]Methods: Forty histologically verified HCC specimens and their neighboring noncancerous tissues were obtained.Immunohistochemistry was used to detect protein expressions of survivin and caspase-3. TUNEL was employed to examine the apoptosis index of HCC tissues. Results:Survivin protein expression was detected in 34 of 40(85%) cases. In contrast, no expression of survivin in corresponding noncancerous tissues was detected. The positive rate of survivin expression in the cases with intrahepatic metastasis was 93.5%,higher than those without intrahepatic metastasis (55.6%,P0.05),and the rate of survivin expression in the cases with portal vein invasion was 92.8%,higher than those without portal vein invasion (66.7%,P0.05). The levels of survivin mRAN in cases with intrahepatic metastasis(1.105±0.396) and portal vein invasion (1.137±0.404)were significantly higher than those without intrahepatic metastasis(0.572±0.082) and portal vein invasion (0.627±0.122,P0.05). The expression of caspase-3 was detected in 15 of 40(37.5%)cases and 77.5% in noncancerous tissues. By TUNEL the survivin expression was significantly associated with reduced apoptosis index[(1.152%±0.326%) vs.( 4.502%±0.830%),P0.05].In contrast caspase-3 expression was associated with increased apoptosis index (5.016%±0.370% vs 1.927%±0.237%,P0.05).The expression of caspase-3 was 29.4% in the cases with survivin expression lower than the cases without survivin expression (83.3%).Conclusion: Survivin expression may play an important role in HCC carcinogenesis. And the expression of survivin is associated with reduced apoptosis index.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the role of survivin and caspase-3expression in the pathogenesis of hepatocellular carcinoma (HCC).[WTHZ]Methods: Forty histologically verified HCC specimens and their neighboring noncancerous tissues were obtained.Immunohistochemistry was used to detect protein expressions of survivin and caspase-3. TUNEL was employed to examine the apoptosis index of HCC tissues. Results:Survivin protein expression was detected in 34 of 40(85%) cases. In contrast, no expression of survivin in corresponding noncancerous tissues was detected. The positive rate of survivin expression in the cases with intrahepatic metastasis was 93.5%,higher than those without intrahepatic metastasis (55.6%,P0.05),and the rate of survivin expression in the cases with portal vein invasion was 92.8%,higher than those without portal vein invasion (66.7%,P0.05). The levels of survivin mRAN in cases with intrahepatic metastasis(1.105±0.396) and portal vein invasion (1.137±0.404)were significantly higher than those without intrahepatic metastasis(0.572±0.082) and portal vein invasion (0.627±0.122,P0.05). The expression of caspase-3 was detected in 15 of 40(37.5%)cases and 77.5% in noncancerous tissues. By TUNEL the survivin expression was significantly associated with reduced apoptosis index[(1.152%±0.326%) vs.( 4.502%±0.830%),P0.05].In contrast caspase-3 expression was associated with increased apoptosis index (5.016%±0.370% vs 1.927%±0.237%,P0.05).The expression of caspase-3 was 29.4% in the cases with survivin expression lower than the cases without survivin expression (83.3%).Conclusion: Survivin expression may play an important role in HCC carcinogenesis. And the expression of survivin is associated with reduced apoptosis index.
Key concepts: Survivin, Hepatocellular carcinoma, Immunohistochemistry, TUNEL assay, Apoptosis, Metastasis, Medicine, Cancer research